Vaxart Inc VXRT:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/22/21 EDT
8.19quote price arrow up+0.11 (+1.36%)
Volume
2,222,974
52 week range
3.50 - 24.90
Loading...
  • Open8.15
  • Day High8.31
  • Day Low8.00
  • Prev Close8.19
  • 52 Week High24.90
  • 52 Week High Date02/02/21
  • 52 Week Low3.50
  • 52 Week Low Date11/09/20

Key Stats

  • Market Cap1.026B
  • Shares Out125.27M
  • 10 Day Average Volume3.34M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change43.43

KEY STATS

  • Open8.15
  • Day High8.31
  • Day Low8.00
  • Prev Close8.19
  • 52 Week High24.90
  • 52 Week High Date02/02/21
  • 52 Week Low3.50
  • 52 Week Low Date11/09/20
  • Market Cap1.026B
  • Shares Out125.27M
  • 10 Day Average Volume3.34M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change43.43

RATIOS/PROFITABILITY

  • EPS (TTM)-0.47
  • P/E (TTM)-17.31
  • Fwd P/E (NTM)-11.70
  • EBITDA (MRQ)-49.682M
  • ROE (MRQ)-45.05%
  • Revenue (MRQ)1.24M
  • Gross Margin (MRQ)5.38%
  • Net Margin (MRQ)-4,363.92%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/10/2021
  • Ex Div Date11/09/2012
  • Div Amount6.648
  • Split Date-
  • Split Factor-

Latest On Vaxart Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vaxart, Inc. is a clinical-stage biotechnology company. The Company is focused on developing oral recombinant vaccines based on its vector-adjuvant-antigen standardized technology (VAAST) proprietary oral vaccine platform. Its oral vaccines are designed to generate immune responses that protect against a range of infectious diseases and will be useful for the treatment of chronic viral infections and cancer. It is developing prophylactic vaccine candidates that target a range...
Wouter Latour M.D.
Non-Executive Chairman
Andrei Floroiu
President
Address
170 Harbor Way, Suite 300
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
NKTX
Nkarta Inc
30.20-0.41-1.34%
AMTI
Applied Molecular Transport Inc.
26.99+0.02+0.07%
ITOS
Iteos Therapeutics Inc
27.46+0.12+0.44%
PHAT
Phathom Pharmaceuticals Inc
31.88-0.70-2.15%
SNDX
Syndax Pharmaceuticals Inc
18.82+0.25+1.35%